Wang Xiaodong

Dr. Xiaodong Wang was born in 1963 in Wuhan, China. He is currently the Director and Senior Investigator of the National Institute of Biological Sciences, Beijing. He received his B.S. degree from Beijing Normal University and his Ph.D. degree of Biochemistry from the University of Texas Southwestern Medical Center in Dallas.

Since 1995, Dr. Wang’s research has mainly focused on the biochemical study of cell apoptosis in the human body. Apoptosis is a special physiological function of cells that plays a crucial role in the human body’s development and the removal of damaged cells. The defect of cell apoptosis is a key step in formulating tumorigenesis. Over the past decades, the laboratory led by Dr. Wang has discovered the biomechanical pathway and its mechanism of action of cell apoptosis. Dr. Wang has developed novel experimental tumor therapy drugs based on these research outcomes that target the treatment of tumor cell apoptosis.

Dr. Wang was named to be a member of the National Academy of Sciences, USA in 2004, a Foreign-associate member of the Chinese Academy of Sciences in 2013, and a foreign member of the European Molecular Biology Organization (EMBO) in 2014. He has received multiple international biological research awards throughout his career, including the Shaw Prize in Life Sciences & Medicine in 2006.